Polymer nanoparticles encased in a cyclodextrin complex shell for potential site- and sequence-specific drug release

Advanced Functional Materials

Volumn 24, Issue 30, 2014, Pages 4753-4761

  Ruiz Esparza, Guillermo U ^a,b   Wu, Suhong ^a   Segura Ibarra, Victor ^a,b   Cara, Francisca E ^a   Evans, Kurt W ^c   Milosevic, Miljan ^d   Ziemys, Arturas ^a   Kojic, Milos ^a,d   Meric Bernstam, Funda ^c   Ferrari, Mauro ^a,e   Blanco, Elvin ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b ESCUELA DE MEDICINA Y CIENCIAS DE LA SALUD   (Mexico)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Belgrade University   (Serbia)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

breast cancer; cyclodextrins; nanoparticle based drug delivery; poly(lactic co glycolic acid) (PLGA); sequential release

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; COPOLYMERS; CYCLODEXTRINS; DISEASES; DRUG DELIVERY; DRUG PRODUCTS; NANOPARTICLES; POLYMERS; TUMORS;

BREAST CANCER; COMBINATION CHEMOTHERAPY; CYCLODEXTRIN COMPLEXES; INTRAVENOUS ADMINISTRATION; POLY(LACTIC-CO-GLYCOLIC ACID); POLYMER NANOPARTICLES; SEQUENCE-SPECIFIC MANNER; SEQUENTIAL RELEASE;

SHELLS (STRUCTURES);

EID: 84905828235     PISSN: 1616301X     EISSN: 16163028     Source Type: Journal    
DOI: 10.1002/adfm.201400011     Document Type: Article

References (41)

1. a) D. J. Butters, D. Ghersi, N. Wilcken, S. J. Kirk, P. T. Mallon, Cochrane Database Syst. Rev. 2010, CD003368
2. b) D. Miles, G. von Minckwitz, A. D. Seidman, The Oncologist 2002, 7, 13.
3. a) M. J. Lee, A. S. Ye, A. K. Gardino, A. M. Heijink, P. K. Sorger, G. MacBeath, M. B. Yaffe, Cell 2012, 149, 780
4. b) W. H. Mondesire, W. Jian, H. Zhang, J. Ensor, M. C. Hung, G. B. Mills, F. Meric-Bernstam, Clin. Cancer Res. 2004, 10, 7031.
5. N. McCarthy, Nat. Rev. Cancer 2012, 12, 449.
6. K. A. Janes, H. C. Reinhardt, M. B. Yaffe, Cell 2008, 135, 343.
7. K. Galoian, H. T. Temple, A. Galoyan, Tumour Biol. 2012, 33, 885.
8. a) A. Hamilton, L. Biganzoli, R. Coleman, L. Mauriac, P. Hennebert, A. Awada, M. Nooij, L. Beex, M. Piccart, I. Van Hoorebeeck, P. Bruning, D. de Valeriola, Ann. Oncol. 2002, 13, 910
9. b) A. Sparreboom, C. D. Scripture, V. Trieu, P. J. Williams, T. De, A. Yang, B. Beals, W. D. Figg, M. Hawkins, N. Desai, Clin. Cancer Res. 2005, 11, 4136.
10. L. D. Mayer, T. O. Harasym, P. G. Tardi, N. L. Harasym, C. R. Shew, S. A. Johnstone, E. C. Ramsay, M. B. Bally, A. S. Janoff, Mol. Cancer Ther. 2006, 5, 1854.
11. A. Gabizon, H. Shmeeda, Y. Barenholz, Clin. Pharmacokin. 2003, 42, 419.
12. W. J. Gradishar, Expert Opin. Pharmacother. 2006, 7, 1041.
13. M. E. Davis, Z. G. Chen, D. M. Shin, Nat. Rev. Drug Discovery 2008, 7, 771.
14. a) M. Ferrari, Nat. Rev. Cancer 2005, 5, 161
15. b) D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, R. Langer, Nat. Nanotechnol. 2007, 2, 751.
16. a) H. Wang, Y. Zhao, Y. Wu, Y. L. Hu, K. Nan, G. Nie, H. Chen, Biomaterials 2011, 32, 8281
17. b) X. Dong, C. A. Mattingly, M. T. Tseng, M. J. Cho, Y. Liu, V. R. Adams, R. J. Mumper, Cancer Res. 2009, 69, 3918.
18. a) E. J. Feldman, J. E. Lancet, J. E. Kolitz, E. K. Ritchie, G. J. Roboz, A. F. List, S. L. Allen, E. Asatiani, L. D. Mayer, C. Swenson, A. C. Louie, J. Clin. Oncol. 2011, 29, 979
19. b) J. R. Hasenstein, H. C. Shin, K. Kasmerchak, D. Buehler, G. S. Kwon, K. R. Kozak, Mol. Cancer Ther. 2012, 11, 2233.
20. a) Z. J. Deng, S. W. Morton, E. Ben-Akiva, E. C. Dreaden, K. E. Shopsowitz, P. T. Hammond, ACS Nano 2013
21. b) S. Sengupta, D. Eavarone, I. Capila, G. Zhao, N. Watson, T. Kiziltepe, R. Sasisekharan, Nature 2005, 436, 568
22. c) E. Tasciotti, X. Liu, R. Bhavane, K. Plant, A. D. Leonard, B. K. Price, M. M. Cheng, P. Decuzzi, J. M. Tour, F. Robertson, M. Ferrari, Nat. Nanotechnol. 2008, 3, 151.
23. a) F. Danhier, E. Ansorena, J. M. Silva, R. Coco, A. Le Breton, V. Preat, J. Controlled Release 2012, 161, 505
24. b) J. K. Vasir, V. Labhasetwar, Adv. Drug Delivery Rev. 2007, 59, 718.
25. a) M. E. Davis, M. E. Brewster, Nat. Rev. Drug Discovery 2004, 3, 1023
26. b) T. Loftsson, M. E. Brewster, J. Pharm. Sci. 2012, 101, 3019
27. c) V. J. Stella, Q. He, Toxicol. Pathol. 2008, 36, 30.
28. C. M. Yam, Z. Xiao, J. Gu, S. Boutet, C. Cai, J. Am. Chem. Soc. 2003, 125, 7498.
29. R. Zhu, S. Howorka, J. Proll, F. Kienberger, J. Preiner, J. Hesse, A. Ebner, V. P. Pastushenko, H. J. Gruber, P. Hinterdorfer, Nat. Nanotechnol. 2010, 5, 788.
30. S. M. Moghimi, A. C. Hunter, J. C. Murray, Pharmacol. Rev. 2001, 53, 283.
31. H. Cabral, Y. Matsumoto, K. Mizuno, Q. Chen, M. Murakami, M. Kimura, Y. Terada, M. R. Kano, K. Miyazono, M. Uesaka, N. Nishiyama, K. Kataoka, Nat. Nanotechnol. 2011, 6, 815.
32. Q. H. Sun, M. Radosz, Y. Q. Shen, J. Controlled Release 2012, 164, 156.
33. P.-O. Gendron, F. Avaltroni, K. Wilkinson, J. Fluorescence 2008, 18, 1093.
34. a) J. Araujo, E. Vega, C. Lopes, M. A. Egea, M. L. Garcia, E. B. Souto, Colloids Surf. B Biointerfaces 2009, 72, 48
35. b) S. Yandrapu, U. B. Kompella, J. Ocul. Pharmacol. Ther. 2013, 29, 236.
36. a) D. S. Jain, R. B. Athawale, A. N. Bajaj, S. S. Shrikhande, P. N. Goel, Y. Nikam, R. P. Gude, Daru 2014, 22, 18
37. b) X. Zhang, Y. Dong, X. Zeng, X. Liang, X. Li, W. Tao, H. Chen, Y. Jiang, L. Mei, S. S. Feng, Biomaterials 2014, 35, 1932.
38. a) S. Ferrati, A. Mack, C. Chiappini, X. Liu, A. J. Bean, M. Ferrari, R. E. Serda, Nanoscale 2010, 2, 1512
39. b) R. Qi, S. Liu, J. Chen, H. Xiao, L. Yan, Y. Huang, X. Jing, J. Controlled Release 2012, 159, 251.
40. C. Stigliano, S. Aryal, M. D. de Tullio, G. P. Nicchia, G. Pascazio, M. Svelto, P. Decuzzi, Mol. Pharmaceutics 2013, 10, 3186.
41. K. A. Woodrow, Y. Cu, C. J. Booth, J. K. Saucier-Sawyer, M. J. Wood, W. M. Saltzman, Nat. Mater. 2009, 8, 526.